Expertise in
10
conditions

Dr. Abirami Sivapiragasam

Obstetrics and Gynecology
Complementary Cancer Care Inc.
86 Jonathan Lucas St, 
Charleston, SC 
Offers Telehealth
Expertise in
10
conditions
Complementary Cancer Care Inc.
86 Jonathan Lucas St, 
Charleston, SC 

Overview

Abirami Sivapiragasam is an Obstetrics and Gynecologist in Charleston, South Carolina. Dr. Sivapiragasam is highly rated in 10 conditions, according to our data. Her top areas of expertise are Breast Cancer, Angiosarcoma, Laryngeal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 23 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Obstetrics and Gynecology

Licenses

Internal Medicine in NY

Hospital Affiliations

Musc Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Complementary Cancer Care Inc.
86 Jonathan Lucas St, Charleston, SC 29425
Other Locations
Carolina Family Care Inc.
1600 Midtown Ave, Mount Pleasant, SC 29464

Additional Areas of Focus

Dr. Sivapiragasam has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
Enrollment Status: Active_not_recruiting
Publish Date: January 26, 2026
Intervention Type: Procedure, Biological, Drug, Radiation
Study Drugs: Docetaxel, Nab-Paclitaxel, Paclitaxel, Pertuzumab, Trastuzumab, Trastuzumab Emtansine
Study Phase: Phase 2
Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study
Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2026
Intervention Type: Drug
Study Drugs: Fulvestrant, Anastrozole
Study Phase: Phase 3
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Enrollment Status: Completed
Publish Date: December 30, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Drugs: Atezolizumab, Paclitaxel, Pertuzumab, Trastuzumab
Study Phase: Phase 3
A Phase II Randomized Study of Adjuvant Versus NeoAdjuvant Pembrolizumab (MK-3475) for Clinically Detectable Stage III-IV High-Risk Melanoma
A Phase II Randomized Study of Adjuvant Versus NeoAdjuvant Pembrolizumab (MK-3475) for Clinically Detectable Stage III-IV High-Risk Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: December 05, 2025
Intervention Type: Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 2
The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib
The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib
Enrollment Status: Active_not_recruiting
Publish Date: October 29, 2025
Intervention Type: Other, Biological, Drug
Study Drugs: Trastuzumab Emtansine, Tucatinib
Study Phase: Phase 3
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
View 6 Less Clinical Trials

23 Total Publications

The impact of adjuvant chemotherapy on overall survival in premenopausal (age ≤ 50 years) hormone and node positive breast cancer patients with an Oncotype Dx score of 25 or less. A NCDB analysis.
The impact of adjuvant chemotherapy on overall survival in premenopausal (age ≤ 50 years) hormone and node positive breast cancer patients with an Oncotype Dx score of 25 or less. A NCDB analysis.
Journal: Breast cancer research and treatment
Published: July 24, 2025
Similar Doctors
Expertise in
15
conditions
Dr. David Soper
Obstetrics and Gynecology
Expertise in
15
conditions
Dr. David Soper
Obstetrics and Gynecology

MUSC University Hospital

171 Ashley Ave, 
Charleston, SC 
 (0.1 miles away)
843-792-2300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Soper is an Obstetrics and Gynecologist in Charleston, South Carolina. Dr. Soper is highly rated in 15 conditions, according to our data. His top areas of expertise are Vulvodynia, Lichen Sclerosus, Pelvic Inflammatory Disease, and Uterine Fibroids.

Expertise in
8
conditions
Dr. Steven Swift
Obstetrics and Gynecology
Expertise in
8
conditions
Dr. Steven Swift
Obstetrics and Gynecology

Office

5500 Front St Ste 350, 
Summerville, SC 
 (20.8 miles away)
843-792-5300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Steven Swift is an Obstetrics and Gynecologist in Summerville, South Carolina. Dr. Swift is highly rated in 8 conditions, according to our data. His top areas of expertise are Urinary Incontinence, Uterine Prolapse, Stress Urinary Incontinence, Rectocele, and Endoscopy.

Expertise in
24
conditions
Dr. Kenosha Gleaton
Obstetrics and Gynecology
Expertise in
24
conditions
Dr. Kenosha Gleaton
Obstetrics and Gynecology

Epicentre LLC

2048 Charlie Hall Blvd, 
Charleston, SC 
 (5.9 miles away)
843-804-6010
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kenosha Gleaton is an Obstetrics and Gynecologist in Charleston, South Carolina. Dr. Gleaton is highly rated in 24 conditions, according to our data. Her top areas of expertise are Amenorrhea, Carney Complex, Solitary Fibrous Tumor, Intrauterine Device Insertion, and Hormone Replacement Therapy (HRT).

Frequently Asked Questions about Dr. Abirami Sivapiragasam

How do I make an appointment with Dr. Abirami Sivapiragasam?

You can book an appointment with Dr. Abirami Sivapiragasam by calling their office at 843-792-9300. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Abirami Sivapiragasam a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Abirami Sivapiragasam is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Abirami Sivapiragasam specialize in?

While Dr. Abirami Sivapiragasam is a Obstetrics and Gynecology, they have specific expertise in Breast Cancer, Angiosarcoma, and Laryngeal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Obstetrics and Gynecology.

Does Dr. Abirami Sivapiragasam participate in research or clinical trials?

Yes. Dr. Abirami Sivapiragasam has published 23 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Abirami Sivapiragasam's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Abirami Sivapiragasam accept my insurance?

Dr. Abirami Sivapiragasam accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 843-792-9300 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sivapiragasam's expertise for a condition
ConditionClose
    View All 58 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile